These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Reduction in short interval intracortical inhibition from the early stage reflects the pathophysiology in amyotrophic lateral sclerosis: A meta-analysis study. Higashihara M; Pavey N; Menon P; van den Bos M; Shibuya K; Kuwabara S; Kiernan MC; Koinuma M; Vucic S Eur J Neurol; 2024 Jul; 31(7):e16281. PubMed ID: 38504632 [TBL] [Abstract][Full Text] [Related]
8. Cortical hyperexcitability precedes lower motor neuron dysfunction in ALS. Menon P; Kiernan MC; Vucic S Clin Neurophysiol; 2015 Apr; 126(4):803-9. PubMed ID: 25227219 [TBL] [Abstract][Full Text] [Related]
9. Cortical thickness in ALS: towards a marker for upper motor neuron involvement. Walhout R; Westeneng HJ; Verstraete E; Hendrikse J; Veldink JH; van den Heuvel MP; van den Berg LH J Neurol Neurosurg Psychiatry; 2015 Mar; 86(3):288-94. PubMed ID: 25121571 [TBL] [Abstract][Full Text] [Related]
10. Distinct neuronal circuits mediate cortical hyperexcitability in amyotrophic lateral sclerosis. Pavey N; Hannaford A; van den Bos M; Kiernan MC; Menon P; Vucic S Brain; 2024 Jul; 147(7):2344-2356. PubMed ID: 38374770 [TBL] [Abstract][Full Text] [Related]
11. A new parameter to discriminate amyotrophic lateral sclerosis patients from healthy participants by motor cortical excitability changes. Cengiz B; Kuruoğlu R Muscle Nerve; 2020 Mar; 61(3):354-362. PubMed ID: 31875983 [TBL] [Abstract][Full Text] [Related]
12. Cortical hyperexcitability and disease spread in amyotrophic lateral sclerosis. Menon P; Geevasinga N; van den Bos M; Yiannikas C; Kiernan MC; Vucic S Eur J Neurol; 2017 Jun; 24(6):816-824. PubMed ID: 28436181 [TBL] [Abstract][Full Text] [Related]
15. Regional motor cortex dysfunction in amyotrophic lateral sclerosis. Menon P; Yiannikas C; Kiernan MC; Vucic S Ann Clin Transl Neurol; 2019 Aug; 6(8):1373-1382. PubMed ID: 31402622 [TBL] [Abstract][Full Text] [Related]
16. Transcallosal inhibition in amyotrophic lateral sclerosis. Wittstock M; Wolters A; Benecke R Clin Neurophysiol; 2007 Feb; 118(2):301-7. PubMed ID: 17140846 [TBL] [Abstract][Full Text] [Related]
17. Transcranial magnetic stimulation (TMS): compared sensitivity of different motor response parameters in ALS. Pouget J; Trefouret S; Attarian S Amyotroph Lateral Scler Other Motor Neuron Disord; 2000 Jun; 1 Suppl 2():S45-9. PubMed ID: 11464941 [TBL] [Abstract][Full Text] [Related]
18. Utility of transcranial magnetic stimulation in delineating amyotrophic lateral sclerosis pathophysiology. Vucic S; Kiernan MC Handb Clin Neurol; 2013; 116():561-75. PubMed ID: 24112924 [TBL] [Abstract][Full Text] [Related]
19. [Objective markers for upper motor neuron involvement in amyotrophic lateral sclerosis]. Iwata NK Brain Nerve; 2007 Oct; 59(10):1053-64. PubMed ID: 17969345 [TBL] [Abstract][Full Text] [Related]
20. Physiological Biomarkers of Upper Motor Neuron Dysfunction in ALS. Calma AD; van den Bos M; Pavey N; Santos Silva C; Menon P; Vucic S Brain Sci; 2024 Jul; 14(8):. PubMed ID: 39199454 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]